UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39334 Biora Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3950390 (State or other jurisdiction of ...

progenity® © 2022 Progenity, Inc. All rights reserved. CORPORATE PRESENTATION March 2022 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presentation, including statements concerning our plans, objectives, goals, strategies, future events, ...

Progenity, Inc. (PROG) Q4 2021 Earnings Conference Call March 28, 2022 4:30 PM ET Company Participants Chuck Padala - Managing Director of LifeSci Advisors Adi Mohanty - Chief Executive Officer Eric d'Esparbes - Chief Financial Officer Conference Call Participants Joseph Pantginis - H.C. Wainwright & Co, LLC Catherine Schulte - Robert W. Baird & Co. Inc. Operator Greetings, and welcome to the Progenity Fourth Quarter and Full-Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39334 PROGENITY, INC. (Exact name of Registrant as specified in its Charter) Delaware 27-3950390 (State or other jurisdiction of inco ...

CORPORATE PRESENTATION November 2021 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presentation, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, plans or intentions ...

THIRD QUARTER 2021 – FINANCIAL RESULTS November 2021 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presentation, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, fin ...

Call Start: 16:30 January 1, 0000 4:55 PM ET Progenity, Inc. (PROG) Q3 2021 Earnings Conference Call November 10, 2021 16:30 ET Company Participants Robert Uhl - Managing Director of ICR, Investor Relations Adi Mohanty - Chief Executive Officer Eric d'Esparbes - Chief Financial Officer Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Progenity Third Quarter 2021 Earnings Call. At this time, all participants are in a listen only note. [Operator Instructions] I wou ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39334 Progenity, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3950390 (State or other jurisdiction of incor ...

/ ® CORPORATE PRESENTATION September 2021 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presentation, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as "may," "might," "will," "ob ...

Progenity, Inc. (PROG) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Robert Uhl - Managing Director Harry Stylli - Chairman and Chief Executive Officer Eric d'Esparbes - Chief Financial Officer Conference Call Participants Steven Mah - Piper Sandler Catherine Schulte - Baird Andrew Cooper - Raymond James Operator Welcome to the Progenity Second Quarter 2021 Earnings Call. [Operator Instructions] I will now turn the call over to Robert Uhl, Managing Director with Westwi ...